SE463851B - Komposition foer behandling av erektil dysfunktion via uretra - Google Patents
Komposition foer behandling av erektil dysfunktion via uretraInfo
- Publication number
- SE463851B SE463851B SE8803087A SE8803087A SE463851B SE 463851 B SE463851 B SE 463851B SE 8803087 A SE8803087 A SE 8803087A SE 8803087 A SE8803087 A SE 8803087A SE 463851 B SE463851 B SE 463851B
- Authority
- SE
- Sweden
- Prior art keywords
- phentolamine
- use according
- nitroglycerin
- active substance
- amount
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/557—Eicosanoids, e.g. leukotrienes or prostaglandins
- A61K31/5575—Eicosanoids, e.g. leukotrienes or prostaglandins having a cyclopentane, e.g. prostaglandin E2, prostaglandin F2-alpha
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0034—Urogenital system, e.g. vagina, uterus, cervix, penis, scrotum, urethra, bladder; Personal lubricants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Urology & Nephrology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Reproductive Health (AREA)
- Emergency Medicine (AREA)
- Gynecology & Obstetrics (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Endocrinology (AREA)
- Biomedical Technology (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Priority Applications (21)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
SE8803087A SE463851B (sv) | 1988-09-02 | 1988-09-02 | Komposition foer behandling av erektil dysfunktion via uretra |
IE268089A IE62587B1 (en) | 1988-09-02 | 1989-08-21 | Composition for the treatment of erectile dysfunction |
NZ230400A NZ230400A (en) | 1988-09-02 | 1989-08-22 | Phentolamine and hydrophilic vehicle for use in treating erectile dysfunction |
ZA896681A ZA896681B (en) | 1988-09-02 | 1989-08-31 | A composition for the treatment of erectile dysfunction |
ES89850282T ES2055677T5 (es) | 1988-09-02 | 1989-08-31 | Composicion para el tratamiento de la disfuncion erectil. |
EP89850282A EP0357581B2 (en) | 1988-09-02 | 1989-08-31 | Composition for the treatment of erectile dysfunction |
CA000610172A CA1335346C (en) | 1988-09-02 | 1989-09-01 | Method of treating erectile dysfunction |
JP1509519A JPH0791199B2 (ja) | 1988-09-02 | 1989-09-01 | 勃起機能障害の治療用組成物 |
PCT/SE1989/000462 WO1990002545A1 (en) | 1988-09-02 | 1989-09-01 | Composition for the treatment of erectile dysfunction |
DE68907909T DE68907909T3 (de) | 1988-09-02 | 1989-09-01 | Präparat zur behandlung von erektionsstörungen. |
AU41994/89A AU638414B2 (en) | 1988-09-02 | 1989-09-01 | Composition for the treatment of erectile dysfunction |
AT89909891T ATE91886T1 (de) | 1988-09-02 | 1989-09-01 | Praeparat zur behandlung von erektionsstoerungen. |
EP89909891A EP0432199B2 (en) | 1988-09-02 | 1989-09-01 | Composition for the treatment of erectile dysfunction |
FI910976A FI102454B1 (fi) | 1988-09-02 | 1991-02-27 | Menetelmä erektiilisen dysfunktion hoitamiseksi käytettävän koostumuksen valmistamiseksi |
NO910828A NO301046B1 (no) | 1988-09-02 | 1991-03-01 | Fremgangsmåte for fremstilling av preparat for behandling av erektil funksjonssvikt |
DK199100364A DK175560B1 (da) | 1988-09-02 | 1991-03-01 | Præparat til behandling af erektiv dysfunktion |
GR90300093T GR900300093T1 (en) | 1988-09-02 | 1991-09-27 | Composition for the treatment of erectile dysfunction |
US08/484,546 US5843961A (en) | 1988-09-02 | 1995-06-07 | Method and composition for treating erectile dysfunction |
US08/485,041 US5886039A (en) | 1988-09-02 | 1995-06-07 | Method and composition for treating erectile dysfunction |
US08/478,982 US5849803A (en) | 1988-09-02 | 1995-06-07 | Method of treating erectile dysfunction with nitroglycerine |
US08/481,609 US5942512A (en) | 1988-09-02 | 1995-06-07 | Method and composition for treating erectile dysfunction |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
SE8803087A SE463851B (sv) | 1988-09-02 | 1988-09-02 | Komposition foer behandling av erektil dysfunktion via uretra |
Publications (3)
Publication Number | Publication Date |
---|---|
SE8803087D0 SE8803087D0 (sv) | 1988-09-02 |
SE8803087L SE8803087L (sv) | 1990-03-03 |
SE463851B true SE463851B (sv) | 1991-02-04 |
Family
ID=20373202
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
SE8803087A SE463851B (sv) | 1988-09-02 | 1988-09-02 | Komposition foer behandling av erektil dysfunktion via uretra |
Country Status (16)
Country | Link |
---|---|
US (4) | US5942512A (da) |
EP (2) | EP0357581B2 (da) |
JP (1) | JPH0791199B2 (da) |
AU (1) | AU638414B2 (da) |
CA (1) | CA1335346C (da) |
DE (1) | DE68907909T3 (da) |
DK (1) | DK175560B1 (da) |
ES (1) | ES2055677T5 (da) |
FI (1) | FI102454B1 (da) |
GR (1) | GR900300093T1 (da) |
IE (1) | IE62587B1 (da) |
NO (1) | NO301046B1 (da) |
NZ (1) | NZ230400A (da) |
SE (1) | SE463851B (da) |
WO (1) | WO1990002545A1 (da) |
ZA (1) | ZA896681B (da) |
Families Citing this family (92)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5236904A (en) * | 1989-09-18 | 1993-08-17 | Senetek, Plc | Erection-inducing methods and compositions |
NZ270871A (en) * | 1990-04-25 | 1999-05-28 | Vivus Inc | Method for treating erectile dysfunction |
US5242391A (en) * | 1990-04-25 | 1993-09-07 | Alza Corporation | Urethral insert for treatment of erectile dysfunction |
US6291528B1 (en) | 1991-07-03 | 2001-09-18 | Nathan Earl Scott | Prostaglandin E1/F2 in combination with prostaglandin F2α for enhancing female sexual arousal |
WO1999030718A2 (en) * | 1997-12-18 | 1999-06-24 | Nathan Earl Scott | PROSTAGLANDIN E2/F2α COMBINATION FOR TREATING IMPOTENCE AND ENHANCING SEXUAL AROUSAL |
US5962528A (en) * | 1991-07-03 | 1999-10-05 | Scott; Nathan Earl | Prostaglandin E2 /F2α combination for treating impotence |
WO1993000894A1 (en) * | 1991-07-03 | 1993-01-21 | Scott Nathan E | Prostaglandin e2 treatment of impotence |
US5981593A (en) * | 1991-07-03 | 1999-11-09 | Scott; Nathan Earl | Prostaglandin E2 treatment of impotence |
US20030181355A1 (en) * | 1992-05-29 | 2003-09-25 | Glenn Jeffrey S. | Method for inhibition of viral infection |
US5503973A (en) * | 1992-05-29 | 1996-04-02 | The Regents Of The University Of California | Method for inhibition of viral morphogenesis |
BR9203277A (pt) * | 1992-08-21 | 1994-03-01 | Cesar Roberto Dias Nahoum | Utilizaccao de drogas eretogenicas e respectivas metodologias de aplicacao |
US5773457A (en) * | 1995-02-15 | 1998-06-30 | Cesar Roberto Dias Nahoum | Compositions |
US5910316A (en) | 1992-08-24 | 1999-06-08 | The United States Of America, As Represented By The Department Of Health And Human Services | Use of nitric oxide-releasing agents to treat impotency |
US5698589A (en) * | 1993-06-01 | 1997-12-16 | International Medical Innovations, Inc. | Water-based topical cream containing nitroglycerin and method of preparation and use thereof |
US5565466A (en) * | 1993-08-13 | 1996-10-15 | Zonagen, Inc. | Methods for modulating the human sexual response |
US5482039A (en) * | 1994-03-25 | 1996-01-09 | Vivus, Inc. | Process for diagnosing erectile dysfunction, and related methods of treatment |
TR199700930T2 (xx) * | 1995-03-14 | 1998-07-21 | Vivus Incorporated | Ereksiyon bozuklu�unu �nlemek i�in y�ntem ve kit. |
US5731339A (en) * | 1995-04-28 | 1998-03-24 | Zonagen, Inc. | Methods and formulations for modulating the human sexual response |
US5861431A (en) * | 1995-06-07 | 1999-01-19 | Iotek, Inc. | Incontinence treatment |
US5718917A (en) * | 1995-12-15 | 1998-02-17 | Harvard Scientific Corporation | PGE-1 containing lyophilized liposomes for use in the treatment of erectile dysfunction |
US5932538A (en) * | 1996-02-02 | 1999-08-03 | Nitromed, Inc. | Nitrosated and nitrosylated α-adrenergic receptor antagonist compounds, compositions and their uses |
US5994294A (en) * | 1996-02-02 | 1999-11-30 | Nitromed, Inc. | Nitrosated and nitrosylated α-adrenergic receptor antagonist compounds, compositions and their uses |
US6323211B1 (en) | 1996-02-02 | 2001-11-27 | Nitromed, Inc. | Compositions and methods for treating sexual dysfunctions |
US6469065B1 (en) | 1996-02-02 | 2002-10-22 | Nitromed, Inc. | Nitrosated and nitrosylated α-adrenergic receptor antagonist, compositions and methods of use |
US6294517B1 (en) | 1996-02-02 | 2001-09-25 | Nitromed, Inc. | Compositions and kits comprising alpha-adrenergic receptor antagonists and nitric oxide donors and methods of use |
GB9608408D0 (en) * | 1996-04-23 | 1996-06-26 | Adams Michael A | Treatment of erectile dysfunction |
IT1292377B1 (it) * | 1997-06-19 | 1999-02-08 | Nicox Sa | Composizioni farmaceutiche a base di prostaglandine |
IT1292426B1 (it) | 1997-06-27 | 1999-02-08 | Nicox Sa | Sali nitrati di ace-inibitori |
WO1999002147A1 (en) | 1997-07-09 | 1999-01-21 | Androsolutions, Inc. | Improved methods and compositions for treating male erectile dysfunction |
US6103765A (en) | 1997-07-09 | 2000-08-15 | Androsolutions, Inc. | Methods for treating male erectile dysfunction |
US6399618B1 (en) | 1997-07-09 | 2002-06-04 | Cardiome Pharma Corp | Compositions and methods for modulating sexual activity |
US5954688A (en) * | 1997-08-26 | 1999-09-21 | Queen's University At Kingston | Everting toroid device for delivering a drug into a body cavity |
US6200288B1 (en) | 1997-08-26 | 2001-03-13 | Queen's University At Kingston | Everting toroid device for insertion into a body cavity |
US5925629A (en) * | 1997-10-28 | 1999-07-20 | Vivus, Incorporated | Transurethral administration of androgenic agents for the treatment of erectile dysfunction |
US5919474A (en) * | 1997-10-28 | 1999-07-06 | Vivus, Inc. | Transurethral administration of vasoactive agents to treat peripheral vascular disease, related vascular diseases, and vascular impotence associated therewith |
US6472425B1 (en) | 1997-10-31 | 2002-10-29 | Nitromed, Inc. | Methods for treating female sexual dysfunctions |
WO1999047923A2 (en) | 1998-03-20 | 1999-09-23 | The Rockefeller University | Assays for screening compounds which interact with cation channel proteins, mutant prokaryotic cation channel proteins, and uses thereof |
US6194433B1 (en) | 1998-10-05 | 2001-02-27 | Neal R. Cutler | Sexual dysfunction in females |
US6132757A (en) * | 1998-05-01 | 2000-10-17 | Neal R. Cutler | Treatment of sexual dysfunction in certain patient groups |
US6426084B1 (en) | 2000-06-19 | 2002-07-30 | Neal R. Cutler | Treatment of sexual dysfunction in certain patient groups |
US6110489A (en) * | 1998-05-01 | 2000-08-29 | Cutler; Neal R. | Use of quinolines and quinolones to treat male erectile dysfunction |
US6132753A (en) * | 1998-05-01 | 2000-10-17 | Neal R. Cutler | Treatment of sexual dysfunction in certain patient groups |
US6187790B1 (en) | 1999-03-04 | 2001-02-13 | Neal R. Cutler | Use of cilostazol for treatment of sexual dysfunction |
US6365590B1 (en) | 1998-05-26 | 2002-04-02 | Saint Louis University | Compounds, compositions and methods for treating erectile dysfunction |
US6124461A (en) * | 1998-05-26 | 2000-09-26 | Saint Louis University, Health Services Center, Research Administration | Compounds, compositions, and methods for treating erectile dysfunction |
US5942545A (en) * | 1998-06-15 | 1999-08-24 | Macrochem Corporation | Composition and method for treating penile erectile dysfunction |
US6482426B1 (en) | 1998-09-17 | 2002-11-19 | Zonagen, Inc. | Compositions for the treatment of male erectile dysfunction |
EP1136072A4 (en) * | 1998-12-02 | 2004-12-15 | Mochida Pharm Co Ltd | PREPARATION FOR ADMINISTRATION IN THE URINARY LADDER |
US6486207B2 (en) | 1998-12-10 | 2002-11-26 | Nexmed (Holdings), Inc. | Compositions and methods for amelioration of human female sexual dysfunction |
US6825234B2 (en) | 1998-12-10 | 2004-11-30 | Nexmed (Holdings) , Inc. | Compositions and methods for amelioration of human female sexual dysfunction |
US7176238B1 (en) | 1999-03-01 | 2007-02-13 | Nitromed Inc. | Nitrostated and nitrosylated prostaglandins, compositions and methods of use |
CA2365782A1 (en) | 1999-04-30 | 2000-11-09 | William E. Pullman | Treatment of female arousal disorder |
US20080108086A1 (en) * | 1999-06-02 | 2008-05-08 | Cantor Thomas L | Parathyroid hormone antagonists and uses thereof |
WO2004028444A2 (en) * | 1999-06-02 | 2004-04-08 | Scantibodies Laboratory, Inc. | Parathyroid hormone antagonists and uses thereof |
AUPQ105799A0 (en) | 1999-06-18 | 1999-07-08 | Victor Chang Cardiac Research Institute, The | Cell growth inhibition |
US6303135B1 (en) | 1999-07-08 | 2001-10-16 | Neal R. Cutler | Use of quinolines and quinolones to treat male erectile dysfunction |
US6693135B2 (en) | 2000-01-10 | 2004-02-17 | Nexmed (Holdings) Incorporated | Prostaglandin compositions and methods of treatment for male erectile dysfunction |
US6323241B1 (en) * | 2000-01-10 | 2001-11-27 | Nexmed (Holdings) Inc. | Prostaglandin compositions and methods of treatment for male erectile dysfunction |
US7105571B2 (en) | 2000-01-10 | 2006-09-12 | Nexmed Holdings, Inc. | Prostaglandin compositions and methods of treatment for male erectile dysfunction |
US6471968B1 (en) | 2000-05-12 | 2002-10-29 | Regents Of The University Of Michigan | Multifunctional nanodevice platform |
EP1365794A2 (en) | 2000-07-21 | 2003-12-03 | Lue, Tom | Prevention and treatment of sexual arousal disorders |
US7223406B2 (en) | 2000-07-21 | 2007-05-29 | The Regents Of The University Of California | Methods and compositions for preventing and treating male erectile dysfunction and female sexual arousal disorder |
WO2002102385A1 (en) * | 2001-06-14 | 2002-12-27 | Sampad Bhattacharya | Compositions comprising cgmppde5 inhibitor for transdermal delivery to the erectile tissue of the penis |
US20040142929A1 (en) * | 2001-07-06 | 2004-07-22 | Ramon Merce-Vidal | Derivatives of aryl (or heteroaryl) azolylcarbinoles for the treatment of urinary incontinence |
CN1203055C (zh) | 2001-09-26 | 2005-05-25 | 朱德煦 | 治疗或预防细菌感染的方法和组合物 |
US7041677B2 (en) | 2002-03-01 | 2006-05-09 | R.T. Alamo Ventures I, Llc | Use of monochloroflosequinan in the treatment of sexual dysfunction |
WO2003075860A2 (en) * | 2002-03-08 | 2003-09-18 | Abgent, Inc. | Detection and modulation of slit and roundabount (robo) mediated angiogenesis and uses thereof |
CA2480099C (en) * | 2002-03-26 | 2019-01-08 | Zensun (Shanghai) Sci-Tech. Ltd. | Erbb3 based methods and compositions for treating neoplasms |
US20030219696A1 (en) * | 2002-05-23 | 2003-11-27 | Moreland Gerald W. | Method and apparatus for preventing backflow in dental saliva evacuators |
WO2003099320A1 (en) | 2002-05-24 | 2003-12-04 | Zensun (Shanghai) Sci-Tech.Ltd | Neuregulin based methods and compositions for treating viral myocarditis and dilated cardiomyopathy |
GB0222522D0 (en) | 2002-09-27 | 2002-11-06 | Controlled Therapeutics Sct | Water-swellable polymers |
KR20040043996A (ko) * | 2002-11-20 | 2004-05-27 | 조나겐, 아이엔씨. | 남성 발기부전치료를 위한 개선된 조성물 |
US7196093B2 (en) * | 2003-04-09 | 2007-03-27 | General Atomics | Reversible inhibitors of SAH hydrolase and uses thereof |
US7517887B2 (en) * | 2003-04-09 | 2009-04-14 | General Atomics | Reversible inhibitors of S-adenosyl-L-homocysteine hydrolase and uses thereof |
US7868011B2 (en) * | 2003-04-09 | 2011-01-11 | General Atomics | Use of reversible inhibitors of S-adenosyl-L-homocysteine hydrolase for treating lupus |
GB0417401D0 (en) | 2004-08-05 | 2004-09-08 | Controlled Therapeutics Sct | Stabilised prostaglandin composition |
CN1869002A (zh) * | 2005-05-27 | 2006-11-29 | 中国科学院上海药物研究所 | 一类非甾体雄激素受体调节剂、其制备方法和用途 |
GB0613333D0 (en) | 2006-07-05 | 2006-08-16 | Controlled Therapeutics Sct | Hydrophilic polyurethane compositions |
GB0613638D0 (en) | 2006-07-08 | 2006-08-16 | Controlled Therapeutics Sct | Polyurethane elastomers |
GB0620685D0 (en) | 2006-10-18 | 2006-11-29 | Controlled Therapeutics Sct | Bioresorbable polymers |
US8889635B2 (en) | 2008-09-30 | 2014-11-18 | The Regents Of The University Of Michigan | Dendrimer conjugates |
US9017644B2 (en) | 2008-11-07 | 2015-04-28 | The Regents Of The University Of Michigan | Methods of treating autoimmune disorders and/or inflammatory disorders |
US8945508B2 (en) | 2009-10-13 | 2015-02-03 | The Regents Of The University Of Michigan | Dendrimer compositions and methods of synthesis |
WO2011059586A2 (en) | 2009-10-30 | 2011-05-19 | The Regents Of The University Of Michigan | Multifunctional small molecules |
CN104762255B (zh) | 2010-06-13 | 2019-05-31 | 中国科学院生物物理研究所 | 由干细胞制备心肌细胞的方法和组合物及其用途 |
WO2013053076A1 (en) | 2011-10-10 | 2013-04-18 | Zensun (Shanghai)Science & Technology Limited | Compositions and methods for treating heart failure |
US9402911B2 (en) | 2011-12-08 | 2016-08-02 | The Regents Of The University Of Michigan | Multifunctional small molecules |
JP6412868B2 (ja) | 2012-07-23 | 2018-10-24 | 中国科学院生物物理研究所 | 多能性幹細胞の心室心筋細胞へのインビトロでの分化を誘導するための方法 |
BR112015006656A8 (pt) | 2012-10-08 | 2020-01-21 | Sensun Shanghai Science & Tech Co Ltd | composições e métodos para o tratamento de insuficiência cardíaca em pacientes diabéticos |
CN112168953A (zh) | 2013-05-22 | 2021-01-05 | 上海泽生科技开发股份有限公司 | 缓释纽兰格林治疗心力衰竭 |
WO2017156762A1 (en) | 2016-03-18 | 2017-09-21 | Institute Of Biophysics, Chinese Academy Of Sciences | A cell culture medium and culture medium supplement |
CN113289002A (zh) | 2020-02-24 | 2021-08-24 | 上海泽生科技开发股份有限公司 | 神经调节蛋白用于预防、治疗或延缓心力衰竭的方法和组合物 |
Family Cites Families (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS52156913A (en) * | 1976-06-21 | 1977-12-27 | Toko Yakuhin Kogyo Kk | Production of injectionable medicine |
US4311707A (en) * | 1979-02-12 | 1982-01-19 | American Cyanamid Company | Process for topically producing cutaneous vasodilation for the treatment of vasospastic or ischemic conditions |
CA1188987A (en) * | 1981-03-06 | 1985-06-18 | Masataka Morishita | Preparation having excellent absorption property |
US4746508A (en) * | 1983-06-06 | 1988-05-24 | Beth Israel Hospital Assn. | Drug administration |
EP0149254A3 (en) * | 1983-12-29 | 1987-01-28 | The Research Foundation Of State University Of New York | Fungicidal polypeptide compositions containing l-histidine |
DE3637157A1 (de) * | 1985-11-01 | 1987-05-21 | Byk Gulden Lomberg Chem Fab | Arzneimittel zur behandlung erektiler dysfunktionen |
EP0266968A3 (en) * | 1986-11-03 | 1988-08-24 | Gérard G. Cohen | Gelled ointment of vasodilating agent |
US4801587A (en) * | 1987-03-02 | 1989-01-31 | Gene Voss | Impotence ointment |
DE3913954A1 (de) * | 1989-04-27 | 1990-10-31 | Stief Georg | Arzneimittel zur behandlung erektiler dysfunktionen |
US5242391A (en) * | 1990-04-25 | 1993-09-07 | Alza Corporation | Urethral insert for treatment of erectile dysfunction |
US5482039A (en) * | 1994-03-25 | 1996-01-09 | Vivus, Inc. | Process for diagnosing erectile dysfunction, and related methods of treatment |
US5583144A (en) * | 1995-02-24 | 1996-12-10 | Kral; John G. | Methods for treating erectile impotence |
-
1988
- 1988-09-02 SE SE8803087A patent/SE463851B/sv not_active IP Right Cessation
-
1989
- 1989-08-21 IE IE268089A patent/IE62587B1/en not_active IP Right Cessation
- 1989-08-22 NZ NZ230400A patent/NZ230400A/xx unknown
- 1989-08-31 ZA ZA896681A patent/ZA896681B/xx unknown
- 1989-08-31 EP EP89850282A patent/EP0357581B2/en not_active Expired - Lifetime
- 1989-08-31 ES ES89850282T patent/ES2055677T5/es not_active Expired - Lifetime
- 1989-09-01 AU AU41994/89A patent/AU638414B2/en not_active Expired
- 1989-09-01 EP EP89909891A patent/EP0432199B2/en not_active Expired - Lifetime
- 1989-09-01 WO PCT/SE1989/000462 patent/WO1990002545A1/en active IP Right Grant
- 1989-09-01 CA CA000610172A patent/CA1335346C/en not_active Expired - Lifetime
- 1989-09-01 JP JP1509519A patent/JPH0791199B2/ja not_active Expired - Lifetime
- 1989-09-01 DE DE68907909T patent/DE68907909T3/de not_active Expired - Lifetime
-
1991
- 1991-02-27 FI FI910976A patent/FI102454B1/fi active
- 1991-03-01 DK DK199100364A patent/DK175560B1/da not_active IP Right Cessation
- 1991-03-01 NO NO910828A patent/NO301046B1/no not_active IP Right Cessation
- 1991-09-27 GR GR90300093T patent/GR900300093T1/el unknown
-
1995
- 1995-06-07 US US08/481,609 patent/US5942512A/en not_active Expired - Lifetime
- 1995-06-07 US US08/484,546 patent/US5843961A/en not_active Expired - Lifetime
- 1995-06-07 US US08/478,982 patent/US5849803A/en not_active Expired - Lifetime
- 1995-06-07 US US08/485,041 patent/US5886039A/en not_active Expired - Lifetime
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
SE463851B (sv) | Komposition foer behandling av erektil dysfunktion via uretra | |
Levine et al. | Gonadotropin-releasing hormone analogues in the treatment of sickle cell anemia-associated priapism | |
Brindley | Maintenance treatment of erectile impotence by cavernosal unstriated muscle relaxant injection | |
US5708031A (en) | Prostaglandin E2 treatment of impotence | |
US5891915A (en) | Method for enhancing female sexual response and an ointment therefor | |
Govier et al. | Experience with triple-drug therapy in a pharmacological erection program | |
Sidi et al. | Clinical experience with vasoactive intracavernous pharmacotherapy for treatment of impotence | |
Wyndaele et al. | Intracavernous injection of vasoactive drugs, an alternative for treating impotence in spinal cord injury patients | |
Halsted et al. | Papaverine-induced priapism: 2 case reports | |
EP0618798B1 (en) | Pyridylguanidine compounds for treatment of erectile dysfunction | |
Watters et al. | Experience in the management of erectile dysfunction using the intracavernosal self-injection of vasoactive drugs | |
EP0459377B1 (en) | Use of E1 prostaglandin to cure male erectile inpotence | |
Fuchs et al. | Papaverine-induced fibrosis of the corpus cavernosum | |
US5561154A (en) | Treatment of acute urinary retention | |
EP0755689A1 (de) | Behandlung der erektilen Dysfunktion | |
CA2243657C (en) | Compositions for treatment of erectile dysfunction | |
Levitt, NS, Vinik, AI, Sive, AA, Klaff, LJ & Phillips | Synthetic luteinizing hormone-releasing hormone in impotent male diabetics-a double-blind cross-over trial | |
Al-Juburi et al. | Penile self-injection for impotence in patients after radical cystectomy-ileal loop | |
RU2201250C2 (ru) | Способ коррекции эректильной дисфункции у больных сахарным диабетом | |
Stief et al. | Intracavernous drug delivery system: an alternative to intracavernous injection in the treatment of impotence? | |
Campbell | Treating erectile dysfunction | |
Beauchesne | Male erectile dysfunction | |
MXPA98004756A (en) | Pge-1 containing lyophilized liposomes to be used in the treatment of erec dysfunction | |
KR20020020536A (ko) | 발기유발제 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
NAL | Patent in force |
Ref document number: 8803087-9 Format of ref document f/p: F |
|
NUG | Patent has lapsed |